Eglonil. Ntuziaka maka ojiji, onunu ogwu na contraindications

N'ọrụ umi nkwadebe "Eglonil" bụ sulpiride, benzamide neuroleptic enwe agafeghị oke neuroleptic ọrụ. Nke a na-emepụta ọgwụ gị n'ụlọnga nwere na ozu stimulant, antidepressant mmetụta.

"Eglonil" (ọrụ isi) na Central ụjọ usoro igbochi dopaminergic anabata nke na-dị na ahụ limbic usoro. Iji nweta ihe kacha dose nke antipsychotic sulpiride mmetụta dị ukwuu karịa 600 mg. Dose 600 mg na-kenyere iji nweta ndị na-akpali akpali, antidepressant edinam.

Na obere doses sulpiride ndinọ Ọzọkwa na ọgwụgwọ nke psychosomatic ọrịa agwa. "Eglonil" ntụziaka egosi irè na mbenata ọjọọ mgbaàmà nke gastric ọnyá afọ. Ọrịa na agbakasị bowel syndrome na-sulpiride, a ọnụ ke siri nke abdominal mgbu.

Na ala Dosages Sulpiride (50-300 mg) eliminates dizziness.

"Eglonil": ntuziaka maka ojiji

The ọgwụ na-achọkwa na ndị ọzọ na-emepụta ọgwụ psychotropic ọgwụ ọjọọ ma ọ bụ mee ka monotherapy:

• na nnukwu na-adịghị ala ala isi mgbaka;
• nnukwu delirious ekwu;
• ịda mbà n'obi nke dị iche iche si malite;
• na ịma jijiji, nchegbu, gosi na okenye ọrịa;
• oké akparamàgwà ọrịa na ụmụaka ndị ruru afọ isii, tinyere autism (50 mg).

"Eglonil": ntuziaka dosing

ngwọta

Ijide nnukwu psychosis (nakwa dị ka na-adịghị ala ala ụdị) e kenyere / m sulpiride injection na a onunu ogwu nke si 400 mg 800 mg. Ọgwụgwọ e mere maka ruo 14 ụbọchị.

"Eglonil" Erere

N'ọnọdụ nke nnukwu na-adịghị ala ala isi mgbaka, delirious agha psychosis, ịda mbà n'obi dọkịta na-ahọrọ a kwa ụbọchị dose nke site na 200 mg na 1000 mg kewara 2-3 doses.

"Eglonil" Capsule

Na ọgwụgwọ nke nchegbu neurosis na mmetụta okenye kenyere ọgwụ na a kwa ụbọchị dose nke si 50 mg 150 mg ruo 4 izu.

Na oké akparamàgwà ọrịa na ụmụ, autism gbakọọ kwa ụbọchị dose ke ichekwa 5 mg kwa 1 n'arọ ahu arọ 10 mg kwa 1 n'arọ.

N'ihi na ọrịa ndị na-ruru agadi, ndị dose of sulpiride bụ ¼ nke mmalite nke ọgwụgwọ, ma ọ bụ ½ nke nkịtị atụ aro dose.

Na yiri diagnoses, karịsịa gbasara akụrụ odida, ndị dibịa na-ebelata dose na enwekwu n'agbata ochichi.

"Eglonil": mmetụta

Ekwe Omume imebi na endocrine usoro: mmepe nke hyperprolactinemia reversible, nke na-egosi galactorrhea, amenorrhea, ịhụ nsọ disruptions, nnọọ adịkarịghị hụrụ mgbaàmà nke gynecomastia, enweghi ike na frigidity. Mgbe ụfọdụ, ọrịa na-eme mkpesa nke oké sweating, omume nke oké ibu.

Ọ na-enwekwu ọrụ nke imeju enzymes.

CNS emegharị na ogologo oge "eglonil": ụra, dizziness, tremor, n'oge dyskinesia.

Na ọgwụ omume, e nwere obere okwu nke tardive dyskinesia, nke na-kwupụtara ịsụ mmegharị nke ire, ihu, mgbe ogologo oge eji, "Eglon".

Mgbe hyperthermia n'ikuku sulpiride kagbuo n'ihi fever na-egosi na likelihood nke a nchoputa "neuroleptic ajọ ọrịa" (CSN).

Obi usoro mgbe ụfọdụ mkpatụ ka n'ikuku "eglonil" tachycardia, ọbara mgbali elu, nnọọ adịkarịghị - mmepe nke orthostatic hypotension, QT prolongation.

Nfụkasị Jeremaya bụ akpụkpọ ọkụ ọkụ.

Eglonil: nkuzi (contraindications)

Sulpiride prolaktinzavisimymi contraindicated na ọrịa na etuto ahụ, hyperprolactinemia, ịṅụbiga mmanya ókè, na okpomọkụ nke ahuhu, manic psychosis, na pheochromocytoma. Ejila "Eglonil" nwa ara na nne.

Aju site igba ogwu n'akwara ọgwụ nke sulpiride ụmụ n'okpuru afọ 18, nakwa dị ka n'ikuku nke capsules ụmụaka n'okpuru 6 afọ.

Na-atụ aro jikọtara na sulpiride agonists nke dopaminergic anabata na sultopride.

Ọgwụ contraindicated na hypersensitivity otu nke Efrata.